levodopa methyl ester has been researched along with Alzheimer Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernardi, G; Esposito, Z; Martorana, A; Palmieri, MG; Pierantozzi, M; Sancesario, G; Stefani, A | 1 |
1 other study(ies) available for levodopa methyl ester and Alzheimer Disease
| Article | Year |
|---|---|
L-dopa modulates motor cortex excitability in Alzheimer's disease patients.
Topics: Acetylcholine; Afferent Pathways; Aged; Aged, 80 and over; Alzheimer Disease; Cholinergic Agents; Dopamine; Dopamine Agents; Evoked Potentials, Motor; Female; Humans; Levodopa; Male; Middle Aged; Motor Cortex; Neural Inhibition; Neural Pathways; Nootropic Agents; Reaction Time; Synaptic Transmission; Time Factors; Transcranial Magnetic Stimulation | 2008 |